Location
United States, North America
Check Size
$100K - $5M
Investment Stage
Focus Areas
About Investor
Kenneth Harrison serves as a Senior Partner at Novo Ventures, investing across medical devices, pharmaceuticals, biotech, health services, health IT, diagnostics, and digital health from pre-seed through Series B stages, with investment ranges typically between $100K and $5.0M. Ken brings experience from his previous role as Senior Market Planning Manager at Genentech, where he guided strategic decision-making for Ophthalmology and HER2 franchises. He also worked as a management consultant at L.E.K. Consulting and as Entrepreneurship Program Manager at QB3/Mission Bay Capital, and holds a PhD in Pharmacology from Yale University.
Similar Investors
Abdul Ly
Seed
,Series A
,Paul Straub
Pre Seed
,Seed
,Shaun Abrahamson
Pre Seed
,Seed
,Riley Florsheim
Pre Seed
,Seed
,Steve Brownlie
Pre Seed
,Seed
,Danielle Graham
Pre Seed
,Seed
,Is this You?
Is this you? Have any edits?
Fill out our update request form and we'll update ASAP

Grow with the Right Investors
This profile is just one example. Our AI matches you with the investors who best fit your stage, industry, and vision.
Start Matching For Free